Predictive Disease Analytics Market Size, Share & Industry Analysis, By Component (Software and Services), By Technology (Machine Learning, Natural Language Processing, and Statistical Modeling), By Deployment (On Premise, Cloud Based, and Hybrid), By Application (Risk Prediction, Disease Progression Forecasting, and Outbreak Surveillance), By Disease Area (Cardiovascular Diseases, Diabetes & Metabolic Disorders, Oncology, Infectious Diseases, and Neurology), By End User (Hospitals & Health Systems, Payers/Insurance Companies, and Public Health Agencies), and Regional Forecast, 2026-2034

Last Updated: August 25, 2026 | Format: PDF | Report ID: FBI119049

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 18.81% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Component, Technology, Deployment, Application, Disease Area, End User, and Region
By Component	Software Services
By Technology	Machine Learning & Deep Learning Natural Language Processing Statistical Modeling & Risk Scoring Time-Series & Spatial Analytics Others
By Deployment	On Premise Cloud Based Hybrid
By Application	Risk Prediction Disease Progression & Prognosis Forecasting Outbreak Surveillance Treatment Response Prediction Readmission, Utilization & Mortality Prediction Chronic Disease Management Others
By Disease Area	Cardiovascular Diseases Diabetes & Metabolic Disorders Oncology Infectious Diseases Neurology Respiratory Diseases Others
By End User	Hospitals & Health Systems Payers / Insurance Companies Public Health Agencies Pharmaceutical & Biotechnology Companies Diagnostic Companies Others
By Region	North America (By Component, Technology, Deployment, Application, Disease Area, End User, and Country) U.S. Canada Europe (By Component, Technology, Deployment, Application, Disease Area, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Component, Technology, Deployment, Application, Disease Area, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Component, Technology, Deployment, Application, Disease Area, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Component, Technology, Deployment, Application, Disease Area, End User, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa